微波辐射下N-[4-(香豆素-3-基)噻唑-2-基]芳醛腙类化合物的合成及生物活性研究

由含不同取代基的芳香醛与氨基硫脲缩合成缩氨基硫脲,继而与α-溴代乙酰基香豆素经微波辐射合成了14种新的N-[4-(香豆素-3-基)噻唑-2-基]芳醛腙类化合物,产率达到69%～97%.其结构通过1H NMR,IR和HRMS进行了确证.试验表明部分目标化合物具有一定的抑菌生物活性.     

含香豆素骨架的缩氨基硫脲化合物的合成和抑菌活性研究

由含不同取代基的水杨醛与乙酰乙酸乙酯在六氢吡啶存在下,得到一系列乙酰基香豆素中间体,然后进一步与氨基硫脲发生缩合反应,得到含有香豆素骨架的缩氨基硫脲化合物,目标化合物的结构均由IR、1H NMR 13C NMR和HRMS确证.它们对大肠杆菌和枯草杆菌具有优良的抑制效果,其中以二氯代的标题化合物的效果最佳.     

1-(4-取代苯基)-4-苯基-5-(2-羟基苄基)氨基-1,2,3-三唑类衍生物的合成及抑菌活性

将邻羟苯基引入1,2,3-三唑结构中, 设计合成了10个1-(4-取代苯基)-4-苯基-5-取代-1,2,3-三唑类衍生物. 首先, 以对位取代的芳胺为原料, 经重氮化、叠氮化、闭环和缩合反应制得1-(4-取代苯基)-4-苯基-5-水杨醛亚胺-1,2,3-三唑类衍生物(3a~3e), 再用硼氢化钠还原制得1-(4-取代苯基)-4-苯基-5-(2-羟基苄基)氨基-1,2,3-三唑类衍生物(4a~4e). 目标化合物的结构经核磁、IR及元素分析确认. 抑菌活性测试表明, 当质量浓度为0.1 mg/L时, 除化合物3e和4e外, 所有化合物对白色念球菌的抑菌率均达95%以上, 对大肠杆菌的抑菌率达85%以上, 具有强抑菌活性, 表明该类化合物在抗菌药物开发方面有重要应用价值.     

2-苯基噻唑-香豆素衍生物的合成与抗肿瘤活性研究

以对羟基硫代苯甲酰胺和3-溴丙酮酸乙酯为原料,经过缩合、烷基化、皂化反应得到2-((4-甲氧基)苯基)噻唑-4-甲酸,再与二溴代烷烃反应得到溴取代的2-((4-甲氧基)苯基)噻唑-4-羧酸酯,最后与4-羟基香豆素反应得到4个2-苯基噻唑-香豆素衍生物。目标化合物的结构经过红外光谱、核磁共振光谱、质谱以及单晶X-射线衍射对结构进行确证。采用CCK8法评价目标化合物对人乳腺癌细胞MCF-7、人乳腺癌顺铂耐药性细胞MCF-7/DDP细胞增殖活性的影响,结果显示当浓度为50μM时,四个化合物都具有一定的抗肿瘤活性,其中化合物5c对两种癌细胞的抑制活性最强,分别为32.44%和17.99%。     

N-取代苯基N'-(6-苯并噻唑基)脲类化合物的合成

为了寻找具有植物细胞激动素活性的新化合物,以苯并噻唑和取代苯胺为原料,将取代苯脲基引入到苯并噻唑的6-位上,合成了7个N-取代苯基N'-(6-苯并噻唑基)脲类化合物,它们的结构经元素分析、IR和1HNMR确定,7个化合物的合成收率分别为74%,76%,85%,82%,70%,73%和72%.     

N-(4-苯基-噻唑-2-基)芳醛腙类化合物的合成

以芳醛与氨基硫脲进行缩合得到缩氨基硫脲, 分别与ω-溴苯乙酮进行成环反应得到了一系列含噻唑环和芳基的腙类化合物, 并通过用¹H NMR、质谱、红外光谱等对化合物进行了结构表征.     

N-[1-(取代苯基)乙基]-2-羟基苯甲酰肼的合成、表征及抑菌活性

依据邻羟基二苯醚及芳香肼类化合物的抗菌特性, 以邻羟苯基为分子核心, 酰肼键为桥基, 设计合成了7种未见报道的N-(取代苯基)乙基-2-羟基苯甲酰肼类化合物. 以水杨酸甲酯为原料, 经肼解反应后与取代苯乙酮缩合, 再与硼氢化钠反应制得目标化合物, 化合物结构经IR, ¹H NMR和元素分析等证实. 抗菌活性测试结果表明, 该类化合物对不同菌株的抑菌活性具有明显的选择性和特异性. 当质量浓度为1×10^-4 g/mL时, 化合物3b和3e对大肠杆菌和白色念珠菌的抑菌率高达100%, 有极强的抑菌活性; 所有化合物对金黄色葡萄球菌的抑菌率均大于70%, 有一定的抑菌活性. 构效关系分析结果表明, 苯基中引入Cl或Br等卤原子能显著增强化合物的抑菌活性, 而引入-NO₂及-CH₃基团则会降低其抑菌活性.     

N-(取代苯氧乙酰基)-N'-(4-苯基噻唑-2-基)硫脲的合成

以取代苯酚和氯乙酸为原料,合成取代苯氧乙酸,然后经过酰氯化,酯化得到取代苯氧乙酰基异硫氰酸酯,再和2-氨基-4-苯基噻唑反应得到4种N-(取代苯氧乙酰基)-N'-(4-苯基噻唑-2-基)硫脲类化合物,其中3种化合物为首次报道。化合物结构经1H NMR、IR和元素分析得到确证。初步室内生测结果表明该类化合物具有一定的抑菌活性。     

N-[4-(N′-取代酰胺基)苯基]马来酰亚胺的合成与表征

N-取代马来酰亚胺(RMI)是一类重要的新型树脂改性单体,由于其具有刚性五元环的结构,能显著提高聚合物的玻璃化温度和热分解温度,改善材料的工艺性和力学性能[1-9]。但文献对于在N-取代基团中引入杂环结构的单体合成报道很少。本文报道了由顺丁烯二酸酐、8-氨基喹啉、对甲苯胺为主要原料合成N-[4-(N′-8-喹林基)苯甲酰胺基]马来酰亚胺(QPM)和N-[4-(N′-4-甲基苯基)苯甲酰胺基]马来酰亚胺(TPM)的方法,并对产物进行了元素分析和1H-NMR、FT-IR表征。同时,由于8-氨基喹啉具有与8-羟基喹啉类似的结构,能表现出较好的光学性能[10,11],以N…     

3-(N-取代苯基-2-乙酰胺基)硫基-4-N-取代邻羟苯基亚胺基-5-甲基-1,2,4-三唑类化合物的合成及生物活性研究

以对称二氨基硫脲为原料,与冰醋酸反应生成5-甲基-4-氨基-1,2,4-三唑-3-硫酮(1);在弱酸性条件下,1与取代水杨醛反应生成席夫碱中间体5-甲基-4-(N-取代邻羟苯基)亚胺基-1,2,4-三唑-3-硫酮(2a～2c);最后在碱性条件下分别与N-取代苯基-2-氯乙酰胺发生烷基化反应生成15种未见报道的目标化合物3-(N-取代苯基-2-乙酰胺基)硫基-4-(N-取代邻羟苯基)亚胺基-5-甲基-1,2,4-三唑(3a～3o),其结构经IR,1H NMR,13C NMR确证.初步生物测试表明,质量分数为0.01%时,3a～3o对白色念珠菌的抑菌率均达90%以上,具有很强的抑菌活性;对金黄色葡萄球菌、大肠杆菌的抑菌率达80%以上,具有较强的抑菌活性.     

新型2-氢醌-多羟基卟啉的合成及其抗菌活性研究

为寻找新的光动力治疗光敏剂,首次利用电中性的对苯二酚与2-硝基-5,10,15,20-四芳基卟啉直接反应,制备了一系列新型2-氢醌-5,10,15,20-四(4-羟基苯基)卟啉,分离产率达90%以上.用青霉素钠做对照,首次研究了2-氢醌-5,10,15,20-四(4-羟基苯基)卟啉及其Ni(Ⅱ),Zn(Ⅱ)配合物对金黄色葡萄球菌(Staphylococcus aureus,ATCC 25923)和大肠杆菌(Escherichia coli,ATCC 25922)的抑菌活性,显示其浓度为80μmol/L时,就能完全抑制金黄色葡萄球菌的生长(而相应的青霉素钠的浓度为320μmol/L),但对大肠杆菌的作用不明显.结果表明,2-氢醌-5,10,15,20-四(4-羟基苯基)卟啉及其金属配合物在杀灭金黄色葡萄球菌等方面具有很好的应用前景.     

Synthesis and Antibacterial Activities of N-[(1-Aryl-3-phenyl-pyrazol-4-yl)methylene]-2-(halo-o-hydroxyphenyl)hydrazide Derivatives

A series of novel N-[(1-aryl-3-phenyl-pyrazol-4-yl)methylene]-2-(halo-o-hydroxyphenyl)hydrazide derivatives was synthesized and the antibacterial activity of each of them was evaluated. The supposed reaction mechanism of acquiring compounds 3a—3d is that catalytic activity is enhanced by the electron-donating groups of the first phenyl ring while decreased by electron-withdrawing groups of that ring. The result of preliminary bioassay shows that the lowest minimal inhibitory concentration(MIC) of the title compounds against Escherichia coli is 2 μg/mL. MIC values against Monilia albican and Staphlococcus aureus are as low as 4 μg/mL. They will be a series of potential antibacterial compounds against fungi and gram-negative bacteria.     

Complexes of cobalt(2+) chloride with hydrochlorides of N-(1,2,4-triazol-5-yl)- and N-(tetrazol-5-yl)benzamidines

We have synthesized complex compounds of Co(2+) chloride with hydrochlorides of N-(1,2,4-triazol-5-yl)benzamidine and N-(tetrazol-5-yl)benzamidine. According to magnetochemistry and electron spectroscopy data, the ligands are coordinated in a bidentate fashion with the N atom of the amidine group and the N atom of the heterocycle with formation of the tetrahedral chromophore CoN₂Cl₂.Institute of Inorganic Chemistry, Siberian Branch, Russian Academy of Sciences, 630090 Novosibirsk. N. D. Zelinskii Institute of Organic Chemistry, Russian Academy of Sciences, 117913 Moscow. Translated from Izvestiya Akademii Nauk, Seriya Khimicheskaya, No. 10, pp. 2311–2315, October, 1992.     

Synthesis of Some 2-(3-Alkyl/aryl-5-trifluoromethylpyrazol-1-yl)-4-(coumarin-3-yl)thiazoles as Novel Antibacterial Agents

Abstract

Herein, we describe a one-pot synthesis of some novel 2-(3-alkyl/aryl-5-trifluoromethylpyrazol-1-yl)-4-(coumarin-3-yl)thiazoles (6) involving the reaction of 3-alkyl/aryl-5-hydroxy-5-trifluoromethyl-4,5-dihydropyrazole-1-thiocarboxamides (3) with 3-bromoacetylcoumarins (5) in the presence of sodium carbonate in ethanol. Reaction of 3 with 5 in the absence of sodium carbonate, however, resulted in the formation of 2-(3-alkyl/aryl-5-hydroxy-5-trifluoromethyl-4,5-dihydropyrazol-1-yl)-4-(coumarin-3-yl)thiazoles, which were subsequently dehydrated to 6 by refluxing in ethanol in the presence of sodium carbonate. The structure of the synthesized compounds (6) was confirmed by infrared (IR), mass, ¹H NMR, and ¹³C NMR spectra and elemental analysis data. Newly synthesized compounds (6) showed moderate to good activity against Gram-positive bacteria.     

Synthesis and anti-TMV activity of novel N-(pyrimidin-5-yl)-N'-phenylureas

In order to find novel leading structures of pesticide,a series of N-（pyrimidin-5-yl）-N’-phenylureas（4a-4h） were designed and synthesized from 4-chloro-2-diethylamino-6-methyl-5-nitropyrimidine 1 via substitution,reduction and acylation procedures. Preliminary bioassay showed that all the target compounds processing good anti-TMV（tobacco mosaic virus） activity.Two compounds（4d and 4e） displayed higher activity superior to virazole at a concentration of 5.0×10^-4g/mL.     

Synthesis and crystal structure of complex of Ce(NO_3)_3 with N-(3-methyl-pyridin-2-yl)-formimidoyl-(3-methyl-pyridin-2-yl) hydrazone

Rare earth complexes with organic ligands have been used as luminescence-material usually. Except their luminescent property, the complexes of trivalent lanthanide ions have low toxicity and powerful para-magnetic properties[1,2], so the lanthanide complexes are associated with important biological uses as diag-nostic tools and medicines[36]. Recently, there are some reports on Ce(III) complexes, some of which show anti-cancer activities[7]. S- tetrazines can be used as poly-dentate chelatin…     

Synthesis,Crystal Structure and Antitumor Activity of N-（4-tert-butyl-5-（4-chlorobenzyl）thiazol-2-yl）-2,6-difluorobenzamide

The title compound was synthesized by the reaction of 4-tert-butyl-5-(4-chlorobenzyl)-2-aminothiazole with 2,6-difluorobenzoic acid. The crystal structure of the title compound, C21H19ClF2N2OS, was determined by single-crystal X-ray diffraction. The crystal belongs to the triclinic system, space group Pbca with a = 12.6479(13), b = 13.1204(13), c = 14.1341(15), Z = 4, V = 2011.5(4)3, Mr = 420.89, Dc = 1.390 g/cm3, S = 1.023, μ = 0.326 mm-1, F(000) = 872, the final R = 0.0365 and wR = 0.0880 for 6101 observed reflections(I 2σ(I)), and R = 0.0507, wR = 0.0978 for 7779 independent reflections. X-ray crystal structure displays that the hydrogen bonding interactions observed link the molecules to form a dimeric unit. The preliminary biological test of the title compound shows good antitumor activity, with IC50 of 0.046 μmol/mL against the Hela cell line.     

N-取代苯基-卤代邻羟基苄胺的合成、表征及抑菌活性

通过卤代水杨醛与取代芳胺缩合、NaBH4还原, 合成了15种N-取代苯基-卤代邻羟基苄胺化合物, 其中14种未见报道. 化合物的结构经IR, 1H NMR, MS与元素分析表征确证. 抑菌测试表明, 在质量浓度为0.05%时, 化合物对白色念珠菌的抑菌率高达100%, 具有强抑菌活性, 对金黄色葡萄球菌、大肠杆菌有一定的抑菌活性. 该类化合物对不同菌株的抑菌活性具有明显的选择性和特异性, 是一类极具潜力的抗真菌化合物. 构效分析表明, 胺基苯环上取代基的类型对化合物抑菌活性有重要影响, 引入F, Cl等卤原子, 能显著增强化合物的抑菌活性, 而引入NO2, OCH3等强吸、供电基团, 能显著降低其抑菌活性; 邻羟基苯环上引入卤原子的类型和数量对化合物抑菌活性有一定影响, 5-溴代化合物比5-氯代化合物、3,5-二溴代化合物对大肠杆菌的抑菌活性更高.     

N-(3,4-二氢-2H-1-苯并吡喃-4)异硫脲类化合物的合成及其血管舒张活性

根据苯并吡喃类钾通道开放剂的作用机理和构效关系, 设计合成了13个苯并吡喃-4-异硫脲衍生物, 其结构经IR, ¹H NMR, MS和元素分析确证. 大鼠体外血管扩张实验研究表明, 多数化合物在1×10^－5 mol•L^－1 浓度下对30 mmol•L^－1 KCl诱导的大鼠主动脉条收缩具有一定程度的抑制作用, 其中化合物6l的血管收缩抑制活性较强.